GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...

This popular spice is beloved by many, but its potential interactions with certain medications are important to be aware of.

Two undergraduate medicine students at University of Galway have led a major study examining how cardioprotective ...

It’s possible that they may play a role as a preventative measure in the future,” said Dr. Catriona Reddin told The Post.

Drugs originally developed to treat type 2 diabetes, particularly GLP-1 receptor agonists such as semaglutide (sold as ...

A concerning number of newly diagnosed patients discontinue their medication within a year. Nearly 40% of patients diagnosed ...

A major new study finds that certain diabetes medications, including GLP-1 and SGLT2 inhibitors, may be linked to a reduced ...

Researchers reviewed data from more than 56 million pregnancies to examine the connection between diabetes and A.D.H.D., ...

Food additive mixtures commonly found in diet drinks, soups, dairy desserts and sauces may slightly increase a person's risk ...

The decision counters a proposal by the Biden Administration to reimburse beneficiaries for the weight-loss medications.

The Centers for Medicare and Medicaid Services said it would not cover the medications under Medicare’s Part D coverage.